Search Results

Site Search

Converging on a major milestone in digital pathology - Insights

Successful implementation of a new slide scanning and analysis platform across five laboratories represents a significant step forward in Mayo Clinic’s digital pathology program — an initiative that combines advanced technology with human...

Hospitals and health systems - Insights

Mayo Clinic Laboratories can help hospital laboratories leverage the power of their labs through advanced, high-quality testing, customized consultative services, and tailored business solutions.

Movement disorders - Insights

Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.

Next-generation sequencing: Examining an often oversimplified & misunderstood technology-Part II - Insights

One of the biggest misunderstandings about genetic testing is a perception that once a variant is identified and analyzed thoroughly, using all the best tools available, it can be associated with a specific disease or condition. But many...

Our Staff, Our Stories: Darin Kittleson - Insights

From friendly neighbor, to a hero. Darin Kittleson was in the middle of his ordinary day snow plowing his driveway when he decided to plow his neighbor’s driveway, as well. That was when he heard the cry for help. Darin rushed inside as 911...

Genetics events - Insights

For more than 50 years, Mayo Clinic Laboratories has been providing meaningful results to individuals seeking genetic answers. Rare genetic disorders can be among the most difficult conditions to diagnose. To provide meaningful answers, our...

B-cell lymphoma - Insights

Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.

New Biomarker Greatly Improves Diagnostic Sensitivity for Rare Kidney Disease, Fibrillary Glomerulonephritis - Insights

A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...

A downward spiral undone: Jon Bratsch - Insights

Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and...

Infectious diseases - Insights

Mayo Clinic offers a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases.